Andrew Cheng

Photo of Andrew Cheng
Title(s)Associate Professor of Clinical Pediatrics
SchoolKeck School of Medicine of Usc
AddressCHLA 4650 W. Sunset Blvd.
Off Campus
Los Angeles CA 90026
ORCID ORCID Icon0000-0002-4860-6218 Additional info
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Andrew Cheng received his B.S. in electrical engineering and computer science from University of California, Berkeley and M.D. from University of Michigan. After medical school, he completed a residency in pediatrics at University of California, Los Angeles, and fellowships in pediatric cardiology and advanced cardiac imaging at Children’s Hospital Los Angeles. Dr. Cheng is currently an Associate Professor of Clinical Pediatrics at USC and an attending Pediatric Cardiologist at Children’s Hospital Los Angeles. His clinical interests include cardiac magnetic resonance imaging, cardiac computed tomography, and care of patients with the Fontan circulation. Dr. Cheng's primary research utilizes cardiac magnetic resonance imaging and computational fluid dynamic simulations to study the role of blood viscosity in Fontan circulation pathophysiology. He is the director of CHLA's multidisciplinary Fontan Clinic and CHLA's site PI for the Fontan Outcomes Network.

    Collapse Biography 
    Collapse education and training
    University of California, BerkeleyB.S.05/2004Electrical Engineering and Computer Science
    University of MichiganM.D.05/2009Medicine
    University of California, Los AngelesResidency06/2012Pediatrics
    Children's Hospital Los AngelesFellowship06/2015Pediatric Cardiology
    Children's Hospital Los AngelesFellowship06/2016Advanced Cardiac Imaging
    Collapse awards and honors
    Children's Hospital Los Angeles2020Nominee, Morris and Mary Press Humanism Award
    University of Southern California2015  - 2016Provost's Postdoctoral Scholar Research Grant
    American Society of Echocardiography2015Travel Grant
    American Academy of Pediatrics2014  - 2015Section on Cardiology and Cardiac Surgery Research Fellowship Award
    Eta Kappa Nu (National Electrical Engineering Honor Society)2001Elected Member
    Tau Beta Pi (National Engineering Honor Society)2001Elected Member

    Collapse Research 
    Collapse research activities and funding
    Impact of Blood Viscosity and Vascular Compliance on Fontan Circulation Dysfunction in Children
    NIH/NHLBI K23HL161310Mar 1, 2022 - Feb 28, 2027
    Role: PI
    American Heart Association Career Development AwardJul 1, 2021 - Jul 31, 2024
    Keck School of Medicine of USC Wright Foundation AwardJul 1, 2018 - Jul 31, 2021
    Saban Research Institute, Children's Hospital Los Angeles Research Career Development AwardJul 1, 2018 - Dec 31, 2020
    Keck School of Medicine of USC Pediatrician Scientist AwardJul 1, 2018 - Jun 30, 2019
    NIH/NICHD K12HD052954Dec 1, 2015 - Nov 30, 2017
    Role: Postdoctoral Scholar

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The Fontan Outcomes Network: Findings After 2 Years and 1121 Participants. Circulation. 2026 Apr 21; 153(16):1182-1195. Glenn TM, Kasparian NA, Amdani S, Renaud D, DiMaria MV, Teh J, Leone DM, Mahendran AK, Pike NA, Dolgner SJ, Cheng AL, Rathod RH, Vaikunth SS, Veeram Reddy SR, Vanam R, Theobald J, Schumacher KR, Hummel SA, Conway J, Goldberg DJ, Zakaria D, Clauss SB, Suthar D, Jacobsen RM, Morell EM, Dykes JC, Weingarten AJ, Bhat DP, Reinking BE, Alsaied T, Lannon C, Allen KY, Anderson JB, Patterson LB, Brown DW, James R, Rychik J, Opotowsky AR, SV-ONE Investigators. PMID: 41878814; PMCID: PMC13157274.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Smoking Prevalence and Cessation in Skin Cancer Survivors. Dermatology. 2026; 242(3):280-283. Smith CA, Cheng A, Escoffery C, Yeung H. PMID: 41712478.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Finding our ROLE: How and why to reframe essentialist approaches to language. Cognition. 2026 Jun; 271:106444. Namboodiripad S, Kutlu E, Babel A, Babel M, Baese-Berk M, Bassuk PB, Block A, Pérez RC, Carlson MT, Carraturo S, Cheng A, Cheng LSP, Combiths P, Foushee R, Frederiksen AT, Grammon D, Hayes-Harb R, Higby E, Kendro K, Koulidobrova E, Lin CC, Lin Z, Luque A, McGowan KB, Muegge JB, Shea C, Tripp A, Woods SJ, Wright KE. PMID: 41539217.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Clinical and echocardiographic features of right ventricular dysfunction and biventricular dysfunction in children. Ann Pediatr Cardiol. 2025 Jul-Aug; 18(4):337-344. Loss KL, Cheng AL, Weisert M, Wang S, Menteer J, Kantor PF, Masood IR, Su JA. PMID: 41725867; PMCID: PMC12924017.
      View in: PubMed   Mentions:
    5. Significance of Reynolds Number Consistency in Non-Newtonian Hemodynamic Simulations: Insights from Fontan Circulation. Phys Fluids (1994). 2025 Aug; 37(8). Bilgi C, Wei H, Cheng AL, Pahlevan NM. PMID: 41510309; PMCID: PMC12777659.
      View in: PubMed   Mentions:
    6. Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial. Lancet. 2025 08 16; 406(10504):719-730. Noureddin M, Frias JP, Neff GW, Lucas KJ, Behling C, Bedossa P, Dubourg J, Chan D, Burch M, Fong E, de Temple B, Minerva M, Barrett K, Shringarpure R, Tillman EJ, Rolph T, Cheng A, Yale K. PMID: 40818852.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    7. Viral Etiologies of Acute Respiratory Illness in Older Adults and of Congestive Heart Failure and Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization During 2 Prepandemic Respiratory Seasons. Open Forum Infect Dis. 2025 Jul; 12(7):ofaf366. Choi C, Ess G, Tippett A, Salazar L, Taylor EG, Ciric C, Reese O, Cheng A, Gibson T, Li W, Hsiao HM, Hellmeister K, Al-Husein Z, Hubler R, Begier E, Liu Q, Uppal S, Kalina WV, Gessner B, Jodar L, Kamidani S, Kao C, Yildirim I, Anderson LJ, Rouphael N, Anderson EJ, Rostad CA. PMID: 40657165; PMCID: PMC12247161.
      View in: PubMed   Mentions:
    8. Corrigendum to "Cardiac manifestations and outcomes of COVID-19 vaccine-associated myocarditis in the young in the USA: longitudinal results from the Myocarditis After COVID Vaccination (MACiV) multicenter study". EClinicalMedicine. 2025 Jun; 84:103268. Jain SS, Anderson SA, Steele JM, Wilson HC, Muniz JC, Soslow JH, Beroukhim RS, Maksymiuk V, Jacquemyn X, Frosch OH, Fonseca B, Harahsheh AS, Buddhe S, Ashwath RC, Thacker D, Maskatia SA, Misra N, Su JA, Siddiqui S, Vaiyani D, Vaikom-House AK, Campbell MJ, Klein J, Huang S, Mathis C, Cornicelli MD, Sharma M, Nagaraju L, Ang JY, Uppu SC, Ramachandran P, Patel JK, Han F, Mandell JG, Akam-Venkata J, DiLorenzo MP, Brumund M, Bhatla P, Eshtehardi P, Mehta K, Glover K, Dove ML, Aldawsari KA, Kumar A, Barfuss SB, Dorfman AL, Minocha PK, Yonts AB, Schauer J, Cheng AL, Robinson JD, Powell Z, Srivastava S, Chelliah A, Sanil Y, Hernandez LE, Gaur L, Antonchak M, Johnston M, Reich JD, Nair N, Drugge ED, Grosse-Wortmann L. PMID: 40496878; PMCID: PMC12148612.
      View in: PubMed   Mentions:
    9. Efruxifermin in Compensated Liver Cirrhosis Caused by MASH. N Engl J Med. 2025 Jun 26; 392(24):2413-2424. Noureddin M, Rinella ME, Chalasani NP, Neff GW, Lucas KJ, Rodriguez ME, Rudraraju M, Patil R, Behling C, Burch M, Chan DC, Tillman EJ, Zari A, de Temple B, Shringarpure R, Jain M, Rolph T, Cheng A, Yale K. PMID: 40341827.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    10. CMR Findings in the Long-Term Outcomes After Multisystem Inflammatory Syndrome in Children (MUSIC) Study. Circ Cardiovasc Imaging. 2025 Sep; 18(9):e017420. Lang SM, Truong DT, Powell AJ, Kazlova V, Newburger JW, Awerbach JD, Binka E, Bradford TT, Cartoski M, Cheng A, DiLorenzo MP, Dionne A, Dorfman AL, Elias MD, Garuba O, Gerardin JF, Hasbani K, Jone PN, Lam CZ, Misra N, Morgan LM, Nutting A, Patel JK, Robinson JD, Schuchardt EL, Sexson Tejtel K, Singh GK, Slesnick TC, Trachtenberg F, Taylor MD, MUSIC Study Investigators. PMID: 40181776; PMCID: PMC12353833.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Nutrition delivery during hospitalisation after critical illness in Australia and New Zealand: a multicentre, prospective observational study. J Hum Nutr Diet. 2025 Feb; 38(1):e13385. Ridley EJ, Ainscough K, Bailey M, Baskett R, Bone A, Campbell L, Capel E, Chapple LA, Cheng A, Deane AM, Doola R, Ferrie S, Fetterplace K, Gilder E, Higgins AM, Hodgson CL, King V, Marshall AP, Nichol A, Peake S, Ramanan M, Neto AS, Udy A, Williams P, Winderlich J, Young PJ, NUTRIENT Study Investigators and ANZICS Clinical Trials Group. PMID: 39587763.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Transcatheter Stenting to Restore Cross-Sectional Area of Extracardiac Fontan Conduits. Catheter Cardiovasc Interv. 2025 04; 105(5):1134-1141. Patel ND, Saadat E, Sullivan PM, Cheng AL, Takao C, Berman DP. PMID: 39887914.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Skin cancer treatment environment and survivorship resources among sexual and gender minority patients: results of the OUT National Cancer Survey. Arch Dermatol Res. 2025 Jan 16; 317(1):253. Smith CA, Machado KTL, Cheng A, Tribble JT, Scout N, Yeung H. PMID: 39820662; PMCID: PMC12279286.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Relative Contribution of Diagnostic Testing to the Diagnosis of Respiratory Syncytial Virus in Hospitalized Adults in the United States. J Infect Dis. 2024 Dec 16; 230(6):1342-1351. Anderson EJ, Tippett A, Begier E, Gibson T, Ess G, Patel V, Taylor M, Reese O, Salazar L, Jadhao S, Sun HY, Hsiao HM, Gupta S, Li W, Stephens K, Keane A, Ciric C, Hellmeister K, Cheng A, Al-Husein Z, Bristow L, Hubler R, Liu Q, Gessner BD, Jodar L, Swerdlow D, Kalina W, Uppal S, Kamidani S, Rouphael N, Anderson LJ, Rostad CA. PMID: 38995029; PMCID: PMC11646620.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    15. The impact of blood viscosity modeling on computational fluid dynamic simulations of pediatric patients with Fontan circulation. Phys Fluids (1994). 2024 Nov; 36(11):111911. Wei H, Bilgi C, Cao K, Detterich JA, Pahlevan NM, Cheng AL. PMID: 39574945; PMCID: PMC11577338.
      View in: PubMed   Mentions:
    16. Cardiac manifestations and outcomes of COVID-19 vaccine-associated myocarditis in the young in the USA: longitudinal results from the Myocarditis After COVID Vaccination (MACiV) multicenter study. EClinicalMedicine. 2024 Oct; 76:102809. Jain SS, Anderson SA, Steele JM, Wilson HC, Muniz JC, Soslow JH, Beroukhim RS, Maksymiuk V, Jacquemyn X, Frosch OH, Fonseca B, Harahsheh AS, Buddhe S, Ashwath RC, Thacker D, Maskatia SA, Misra N, Su JA, Siddiqui S, Vaiyani D, Vaikom-House AK, Campbell MJ, Klein J, Huang S, Mathis C, Cornicelli MD, Sharma M, Nagaraju L, Ang JY, Uppu SC, Ramachandran P, Patel JK, Han F, Mandell JG, Akam-Venkata J, DiLorenzo MP, Brumund M, Bhatla P, Eshtehardi P, Mehta K, Glover K, Dove ML, Aldawsari KA, Kumar A, Barfuss SB, Dorfman AL, Minocha PK, Yonts AB, Schauer J, Cheng AL, Robinson JD, Powell Z, Srivastava S, Chelliah A, Sanil Y, Hernandez LE, Gaur L, Antonchak M, Johnston M, Reich JD, Nair N, Drugge ED, Grosse-Wortmann L. PMID: 39290640; PMCID: PMC11406334.
      View in: PubMed   Mentions: 6  
    17. Analyzing RNA-Seq data from Chlamydia with super broad transcriptomic activation: challenges, solutions, and implications for other systems. BMC Genomics. 2024 Aug 25; 25(1):801. Wan D, Cheng A, Wang Y, Zhong G, Li WV, Fan H. PMID: 39182031; PMCID: PMC11344909.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    18. Influenza Vaccine Effectiveness Pre-pandemic Among Adults Hospitalized With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease and Older Adults. Clin Infect Dis. 2024 04 10; 78(4):1065-1072. Tippett A, Ess G, Hussaini L, Reese O, Salazar L, Kelly M, Taylor M, Ciric C, Keane A, Cheng A, Gibson T, Li W, Hsiao HM, Bristow L, Hellmeister K, Al-Husein Z, Hubler R, Begier E, Liu Q, Gessner B, Swerdlow DL, Kamidani S, Kao C, Yildirim I, Rouphael N, Rostad CA, Anderson EJ. PMID: 37946601.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    19. Safety and Efficacy of Efruxifermin in Combination With a GLP-1 Receptor Agonist in Patients With NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study. Clin Gastroenterol Hepatol. 2025 01; 23(1):103-113. Harrison SA, Frias JP, Lucas KJ, Reiss G, Neff G, Bollepalli S, Su Y, Chan D, Tillman EJ, Moulton A, de Temple B, Zari A, Shringarpure R, Rolph T, Cheng A, Yale K. PMID: 38447814.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    20. Nurse and Social Worker Palliative Telecare Team and Quality of Life in Patients With COPD, Heart Failure, or Interstitial Lung Disease: The ADAPT Randomized Clinical Trial. JAMA. 2024 01 16; 331(3):212-223. Bekelman DB, Feser W, Morgan B, Welsh CH, Parsons EC, Paden G, Baron A, Hattler B, McBryde C, Cheng A, Lange AV, Au DH. PMID: 38227034; PMCID: PMC10792473.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    21. Decreased erythrocyte aggregation in Glenn and Fontan: univentricular circulation as a rheologic disease model. Pediatr Res. 2024 04; 95(5):1335-1345. Suriany S, Liu H, Cheng AL, Wenby R, Patel N, Badran S, Meiselman HJ, Denton C, Coates TD, Wood JC, Detterich JA. PMID: 38177250; PMCID: PMC11798010.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    22. Requirement of GrgA for Chlamydia infectious progeny production, optimal growth, and efficient plasmid maintenance. mBio. 2024 01 16; 15(1):e0203623. Lu B, Wang Y, Wurihan W, Cheng A, Yeung S, Fondell JD, Lai Z, Wan D, Wu X, Li WV, Fan H. PMID: 38112466; PMCID: PMC10790707.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    23. Cardiovascular Follow-up of Patients Treated for MIS-C. Pediatrics. 2023 12 01; 152(6). Zimmerman D, Shwayder M, Souza A, Su JA, Votava-Smith J, Wagner-Lees S, Kaneta K, Cheng A, Szmuszkovicz J. PMID: 37964674.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    24. Atopic Dermatitis and Bullying Among US Adolescents. JAMA Dermatol. 2023 12 01; 159(12):1395-1397. Cheng A, Wan J, Chen SC, Yeung H. PMID: 37878280; PMCID: PMC10600718.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    25. Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Gastroenterol Hepatol. 2023 12; 8(12):1080-1093. Harrison SA, Frias JP, Neff G, Abrams GA, Lucas KJ, Sanchez W, Gogia S, Sheikh MY, Behling C, Bedossa P, Shao L, Chan D, Fong E, de Temple B, Shringarpure R, Tillman EJ, Rolph T, Cheng A, Yale K, HARMONY Study Group. PMID: 37802088.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansCTClinical Trials
    26. Requirement of GrgA for Chlamydia infectious progeny production, optimal growth, and efficient plasmid maintenance. bioRxiv. 2023 Aug 02. Lu B, Wang Y, Wurihan W, Cheng A, Yeung S, Fondell JD, Lai Z, Wan D, Wu X, Li WV, Fan H. PMID: 37577610; PMCID: PMC10418237.
      View in: PubMed   Mentions:
    27. Screening left ventricular systolic dysfunction in children using intrinsic frequencies of carotid pressure waveforms measured by a novel smartphone-based device. Physiol Meas. 2023 03 01; 44(3). Cheng AL, Liu J, Bravo S, Miller JC, Pahlevan NM. PMID: 36753767; PMCID: PMC11073485.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. Benchmarking cell-type clustering methods for spatially resolved transcriptomics data. Brief Bioinform. 2023 01 19; 24(1). Cheng A, Hu G, Li WV. PMID: 36410733; PMCID: PMC9851325.
      View in: PubMed   Mentions: 34     Fields:    Translation:Cells
    29. Examination of Adverse Reactions After COVID-19 Vaccination Among Patients With a History of Multisystem Inflammatory Syndrome in Children. JAMA Netw Open. 2023 01 03; 6(1):e2248987. Elias MD, Truong DT, Oster ME, Trachtenberg FL, Mu X, Jone PN, Mitchell EC, Dummer KB, Sexson Tejtel SK, Osakwe O, Thacker D, Su JA, Bradford TT, Burns KM, Campbell MJ, Connors TJ, D'Addese L, Forsha D, Frosch OH, Giglia TM, Goodell LR, Handler SS, Hasbani K, Hebson C, Krishnan A, Lang SM, McCrindle BW, McHugh KE, Morgan LM, Payne RM, Sabati A, Sagiv E, Sanil Y, Serrano F, Newburger JW, Dionne A, Pediatric Heart Network MUSIC Study Investigators. PMID: 36595296; PMCID: PMC9857632.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    30. A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis. JHEP Rep. 2023 Jan; 5(1):100563. Harrison SA, Ruane PJ, Freilich B, Neff G, Patil R, Behling C, Hu C, Shringarpure R, de Temple B, Fong E, Tillman EJ, Rolph T, Cheng A, Yale K. PMID: 36644237; PMCID: PMC9832280.
      View in: PubMed   Mentions: 49  
    31. Myocardial Iron Overload Causes Subclinical Myocardial Dysfunction in Sickle Cell Disease. JACC Cardiovasc Imaging. 2022 08; 15(8):1510-1512. Fujikura K, Cheng AL, Suriany S, Detterich J, Arai AE, Wood JC. PMID: 35926908; PMCID: PMC9726199.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    32. Effects of brain tissue oxygen (PbtO2) guided management on patient outcomes following severe traumatic brain injury: A systematic review and meta-analysis. J Clin Neurosci. 2022 May; 99:349-358. Hays LMC, Udy A, Adamides AA, Anstey JR, Bailey M, Bellapart J, Byrne K, Cheng A, Jamie Cooper D, Drummond KJ, Haenggi M, Jakob SM, Higgins AM, Lewis PM, Hunn MK, McNamara R, Menon DK, Murray L, Reddi B, Trapani T, Vallance S, Young PJ, Diaz-Arrastia R, Shutter L, Murray PT, Curley GF, Nichol A. PMID: 35364437.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    33. An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients. iScience. 2021 Nov 19; 24(11):103221. NeuroLINCS Consortium, Li J, Lim RG, Kaye JA, Dardov V, Coyne AN, Wu J, Milani P, Cheng A, Thompson TG, Ornelas L, Frank A, Adam M, Banuelos MG, Casale M, Cox V, Escalante-Chong R, Daigle JG, Gomez E, Hayes L, Holewenski R, Lei S, Lenail A, Lima L, Mandefro B, Matlock A, Panther L, Patel-Murray NL, Pham J, Ramamoorthy D, Sachs K, Shelley B, Stocksdale J, Trost H, Wilhelm M, Venkatraman V, Wassie BT, Wyman S, Yang S, NYGC ALS Consortium, Van Eyk JE, Lloyd TE, Finkbeiner S, Fraenkel E, Rothstein JD, Sareen D, Svendsen CN, Thompson LM. PMID: 34746695; PMCID: PMC8554488.
      View in: PubMed   Mentions: 33  
    34. The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives. Am Heart J. 2022 01; 243:43-53. Truong DT, Trachtenberg FL, Pearson GD, Dionne A, Elias MD, Friedman K, Hayes KH, Mahony L, McCrindle BW, Oster ME, Pemberton V, Powell AJ, Russell MW, Shekerdemian LS, Son MB, Taylor M, Newburger JW, MUSIC Study Investigators (Supplement 1). PMID: 34418362; PMCID: PMC8710361.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    35. Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial. Nat Med. 2021 07; 27(7):1262-1271. Harrison SA, Ruane PJ, Freilich BL, Neff G, Patil R, Behling CA, Hu C, Fong E, de Temple B, Tillman EJ, Rolph TP, Cheng A, Yale K. PMID: 34239138.
      View in: PubMed   Mentions: 161     Fields:    Translation:HumansCTClinical Trials
    36. Fully‑automated deep‑learning segmentation of pediatric cardiovascular magnetic resonance of patients with complex congenital heart diseases. J Cardiovasc Magn Reson. 2020 11 30; 22(1):80. Karimi-Bidhendi S, Arafati A, Cheng AL, Wu Y, Kheradvar A, Jafarkhani H. PMID: 33256762; PMCID: PMC7706241.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    37. Progression in Fontan conduit stenosis and hemodynamic impact during childhood and adolescence. J Thorac Cardiovasc Surg. 2021 Aug; 162(2):372-380.e2. Patel ND, Friedman C, Herrington C, Wood JC, Cheng AL. PMID: 33220959.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    38. Assessing non-Mendelian inheritance in inherited axonopathies. Genet Med. 2020 12; 22(12):2114-2119. Bis-Brewer DM, Gan-Or Z, Sleiman P, Inherited Neuropathy Consortium, Hakonarson H, Fazal S, Courel S, Cintra V, Tao F, Estiar MA, Tarnopolsky M, Boycott KM, Yoon G, Suchowersky O, Dupré N, Cheng A, Lloyd TE, Rouleau G, Schüle R, Züchner S. PMID: 32741968; PMCID: PMC7710562.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    39. Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 Exposure. Vaccines (Basel). 2020 Jun 30; 8(3). Lai L, Ault K, Rouphael N, Beck A, Domjahn B, Xu Y, Anderson EJ, Cheng A, Nakamura A, Hoagland RJ, Kelley C, Edupuganti S, Mask K, Nesin M, Unger ER, Panicker G, David H, Mulligan MJ. PMID: 32629943; PMCID: PMC7563427.
      View in: PubMed   Mentions: 4  
    40. Biventricular Repair in Interrupted Aortic Arch and Ventricular Septal Defect With a Small Left Ventricular Outflow Tract. Ann Thorac Surg. 2021 02; 111(2):637-644. Mallios DN, Gray WH, Cheng AL, Wells WJ, Starnes VA, Kumar SR. PMID: 32599045.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    41. Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients. Cell Rep Med. 2020 06 23; 1(3):100040. Suthar MS, Zimmerman MG, Kauffman RC, Mantus G, Linderman SL, Hudson WH, Vanderheiden A, Nyhoff L, Davis CW, Adekunle O, Affer M, Sherman M, Reynolds S, Verkerke HP, Alter DN, Guarner J, Bryksin J, Horwath MC, Arthur CM, Saakadze N, Smith GH, Edupuganti S, Scherer EM, Hellmeister K, Cheng A, Morales JA, Neish AS, Stowell SR, Frank F, Ortlund E, Anderson EJ, Menachery VD, Rouphael N, Mehta AK, Stephens DS, Ahmed R, Roback JD, Wrammert J. PMID: 32835303; PMCID: PMC7276302.
      View in: PubMed   Mentions: 342     Fields:    
    42. Proof-of-concept for a non-invasive, portable, and wireless device for cardiovascular monitoring in pediatric patients. PLoS One. 2020; 15(1):e0227145. Miller JC, Shepherd J, Rinderknecht D, Cheng AL, Pahlevan NM. PMID: 31899768; PMCID: PMC6941801.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    43. A 4D flow MRI evaluation of the impact of shear-dependent fluid viscosity on in vitro Fontan circulation flow. Am J Physiol Heart Circ Physiol. 2019 12 01; 317(6):H1243-H1253. Cheng AL, Wee CP, Pahlevan NM, Wood JC. PMID: 31585044; PMCID: PMC6962620.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    44. Artificial intelligence in pediatric and adult congenital cardiac MRI: an unmet clinical need. Cardiovasc Diagn Ther. 2019 Oct; 9(Suppl 2):S310-S325. Arafati A, Hu P, Finn JP, Rickers C, Cheng AL, Jafarkhani H, Kheradvar A. PMID: 31737539; PMCID: PMC6837938.
      View in: PubMed   Mentions: 21  
    45. Methamphetamine-Induced Tachydysrhythmia in an Adolescent in Diabetic Ketoacidosis. J Emerg Med. 2019 Jun; 56(6):e111-e114. Vo A, Nguyen MB, Song JL, Cheng AL, Festekjian A. PMID: 30879847.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trial. Lancet HIV. 2018 Dec 13. Eron JJ, Lelievre JD, Kalayjian R, Slim J, Wurapa AK, Stephens JL, McDonald C, Cua E, Wilkin A, Schmied B, McKellar M, Cox S, Majeed SR, Jiang S, Cheng A, Das M, SenGupta D. PMID: 30555051.
      View in: PubMed   Mentions: 17     Fields:    
    47. Differences in Right Ventricular Physiologic Response to Chronic Volume Load in Patients with Repaired Pulmonary Atresia Intact Ventricular Septum/Critical Pulmonary Stenosis Versus Tetralogy of Fallot. Pediatr Cardiol. 2019 Mar; 40(3):526-536. Cheng AL, Kaslow AM, Pruetz JD, Lu JC, Wood JC, Detterich JA. PMID: 30353312; PMCID: PMC9704369.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    48. Switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from dolutegravir plus abacavir and lamivudine in virologically suppressed adults with HIV-1: 48 week results of a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial. Lancet HIV. 2018 07; 5(7):e357-e365. Molina JM, Ward D, Brar I, Mills A, Stellbrink HJ, López-Cortés L, Ruane P, Podzamczer D, Brinson C, Custodio J, Liu H, Andreatta K, Martin H, Cheng A, Quirk E. PMID: 29925489.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCellsCTClinical Trials
    49. Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1: 48 week results of a randomised, open-label, multicentre, phase 3, non-inferiority trial. Lancet HIV. 2018 07; 5(7):e347-e356. Daar ES, DeJesus E, Ruane P, Crofoot G, Oguchi G, Creticos C, Rockstroh JK, Molina JM, Koenig E, Liu YP, Custodio J, Andreatta K, Graham H, Cheng A, Martin H, Quirk E. PMID: 29925490.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCellsCTClinical Trials
    50. Brief Report: Efficacy and Safety of Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (E/C/F/TAF) in Virologically Suppressed Women. J Acquir Immune Defic Syndr. 2018 06 01; 78(2):209-213. Hodder S, Squires K, Kityo C, Hagins D, Avihingsanon A, Kido A, Jiang S, Kulkarni R, Cheng A, Cao H. PMID: 29481486; PMCID: PMC6425939.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    51. Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial. Lancet HIV. 2018 04; 5(4):e162-e171. Winston A, Post FA, DeJesus E, Podzamczer D, Di Perri G, Estrada V, Raffi F, Ruane P, Peyrani P, Crofoot G, Mallon PWG, Castelli F, Yan M, Cox S, Das M, Cheng A, Rhee MS. PMID: 29475804.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    52. Experimental Investigation of the Effect of Non-Newtonian Behavior of Blood Flow in the Fontan Circulation. Eur J Mech B Fluids. 2018 Mar-Apr; 68:184-192. Cheng AL, Pahlevan NM, Rinderknecht DG, Wood JC, Gharib M. PMID: 29736127; PMCID: PMC5935448.
      View in: PubMed   Mentions: 13  
    53. Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial. Lancet. 2017 Nov 04; 390(10107):2063-2072. Gallant J, Lazzarin A, Mills A, Orkin C, Podzamczer D, Tebas P, Girard PM, Brar I, Daar ES, Wohl D, Rockstroh J, Wei X, Custodio J, White K, Martin H, Cheng A, Quirk E. PMID: 28867497.
      View in: PubMed   Mentions: 153     Fields:    Translation:HumansCTClinical Trials
    54. Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Lancet. 2017 Nov 04; 390(10107):2073-2082. Sax PE, Pozniak A, Montes ML, Koenig E, DeJesus E, Stellbrink HJ, Antinori A, Workowski K, Slim J, Reynes J, Garner W, Custodio J, White K, SenGupta D, Cheng A, Quirk E. PMID: 28867499.
      View in: PubMed   Mentions: 138     Fields:    Translation:HumansCTClinical Trials
    55. Brief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results. J Acquir Immune Defic Syndr. 2017 06 01; 75(2):211-218. Arribas JR, Thompson M, Sax PE, Haas B, McDonald C, Wohl DA, DeJesus E, Clarke AE, Guo S, Wang H, Callebaut C, Plummer A, Cheng A, Das M, McCallister S. PMID: 28282300.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    56. Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults. J Acquir Immune Defic Syndr. 2017 06 01; 75(2):226-231. Raffi F, Orkin C, Clarke A, Slama L, Gallant J, Daar E, Henry K, Santana-Bagur J, Stein DK, Bellos N, Scarsella A, Yan M, Abram ME, Cheng A, Rhee MS. PMID: 28272164; PMCID: PMC5427981.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    57. 6q25.1 (TAB2) microdeletion syndrome: Congenital heart defects and cardiomyopathy. Am J Med Genet A. 2017 Jul; 173(7):1848-1857. Cheng A, Dinulos MBP, Neufeld-Kaiser W, Rosenfeld J, Kyriss M, Madan-Khetarpal S, Risheg H, Byers PH, Liu YJ. PMID: 28464518.
      View in: PubMed   Mentions: 14     Fields:    
    58. Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults. J Acquir Immune Defic Syndr. 2017 05 01; 75(1):61-66. Gallant JE, Thompson M, DeJesus E, Voskuhl GW, Wei X, Zhang H, White K, Cheng A, Quirk E, Martin H. PMID: 28196003; PMCID: PMC5389589.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCellsCTClinical Trials
    59. Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3 trial. HIV Clin Trials. 2017 05; 18(3):135-140. Post FA, Yazdanpanah Y, Schembri G, Lazzarin A, Reynes J, Maggiolo F, Yan M, Abram ME, Tran-Muchowski C, Cheng A, Rhee MS. PMID: 28303753.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    60. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study. Lancet HIV. 2017 05; 4(5):e195-e204. Orkin C, DeJesus E, Ramgopal M, Crofoot G, Ruane P, LaMarca A, Mills A, Vandercam B, de Wet J, Rockstroh J, Lazzarin A, Rijnders B, Podzamczer D, Thalme A, Stoeckle M, Porter D, Liu HC, Cheng A, Quirk E, SenGupta D, Cao H. PMID: 28259777.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCellsCTClinical Trials
    61. Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study. Lancet HIV. 2017 05; 4(5):e205-e213. DeJesus E, Ramgopal M, Crofoot G, Ruane P, LaMarca A, Mills A, Martorell CT, de Wet J, Stellbrink HJ, Molina JM, Post FA, Valero IP, Porter D, Liu Y, Cheng A, Quirk E, SenGupta D, Cao H. PMID: 28259776.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCellsCTClinical Trials
    62. Bictegravir versus dolutegravir, each with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection: a randomised, double-blind, phase 2 trial. Lancet HIV. 2017 04; 4(4):e154-e160. Sax PE, DeJesus E, Crofoot G, Ward D, Benson P, Dretler R, Mills A, Brinson C, Peloquin J, Wei X, White K, Cheng A, Martin H, Quirk E. PMID: 28219610.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCellsCTClinical Trials
    63. A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults. J Acquir Immune Defic Syndr. 2017 Feb 01; 74(2):193-200. Huhn GD, Tebas P, Gallant J, Wilkin T, Cheng A, Yan M, Zhong L, Callebaut C, Custodio JM, Fordyce MW, Das M, McCallister S. PMID: 27753684; PMCID: PMC5228611.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCellsCTClinical Trials
    64. Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study. J Acquir Immune Defic Syndr. 2017 Feb 01; 74(2):180-184. Post FA, Tebas P, Clarke A, Cotte L, Short WR, Abram ME, Jiang S, Cheng A, Das M, Fordyce MW. PMID: 27673443; PMCID: PMC5228610.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    65. Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide. EBioMedicine. 2016 Nov; 13:321-327. Funderburg NT, McComsey GA, Kulkarni M, Bannerman T, Mantini J, Thornton B, Liu HC, Zhang Y, Song Q, Fang L, Dinoso J, Cheng A, McCallister S, Fordyce MW, Das M. PMID: 27742226; PMCID: PMC5264242.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    66. Skeletal muscle power and fatigue at the tolerable limit of ramp-incremental exercise in COPD. J Appl Physiol (1985). 2016 12 01; 121(6):1365-1373. Cannon DT, Coelho AC, Cao R, Cheng A, Porszasz J, Casaburi R, Rossiter HB. PMID: 27660300.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    67. Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study. Lancet HIV. 2016 09; 3(9):e410-e420. Squires K, Kityo C, Hodder S, Johnson M, Voronin E, Hagins D, Avihingsanon A, Koenig E, Jiang S, White K, Cheng A, Szwarcberg J, Cao H. PMID: 27562742; PMCID: PMC5825001.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    68. Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results. J Acquir Immune Defic Syndr. 2016 May 01; 72(1):58-64. Wohl D, Oka S, Clumeck N, Clarke A, Brinson C, Stephens J, Tashima K, Arribas JR, Rashbaum B, Cheret A, Brunetta J, Mussini C, Tebas P, Sax PE, Cheng A, Zhong L, Callebaut C, Das M, Fordyce M, GS-US-2, 92-01040111 and Study Team. PMID: 26829661.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCellsCTClinical Trials
    69. Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study. J Acquir Immune Defic Syndr. 2016 Apr 15; 71(5):530-7. Pozniak A, Arribas JR, Gathe J, Gupta SK, Post FA, Bloch M, Avihingsanon A, Crofoot G, Benson P, Lichtenstein K, Ramgopal M, Chetchotisakd P, Custodio JM, Abram ME, Wei X, Cheng A, McCallister S, SenGupta D, Fordyce MW, GS-US-292-0112 Study Team. PMID: 26627107; PMCID: PMC4804743.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCTClinical Trials
    70. Prenatal diagnosis of tetralogy of Fallot with a double aortic arch. Cardiol Young. 2016 Jun; 26(5):973-5. Cheng AL, Pruetz JD, Kung GC. PMID: 26983561.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    71. Validation of a classification system for causes of death in critical care: an assessment of inter-rater reliability. Crit Care Resusc. 2016 Mar; 18(1):50-4. Ridgeon E, Bellomo R, Myburgh J, Saxena M, Weatherall M, Jahan R, Arawwawala D, Bell S, Butt W, Camsooksai J, Carle C, Cheng A, Cirstea E, Cohen J, Cranshaw J, Delaney A, Eastwood G, Eliott S, Franke U, Gantner D, Green C, Howard-Griffin R, Inskip D, Litton E, MacIsaac C, McCairn A, Mahambrey T, Moondi P, Newby L, O'Connor S, Pegg C, Pope A, Reschreiter H, Richards B, Robertson M, Rodgers H, Shehabi Y, Smith I, Smith J, Smith N, Tilsley A, Whitehead C, Willett E, Wong K, Woodford C, Wright S, Young P. PMID: 26947416.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    72. Left bronchial compression and pulmonary hypertension related to anomalous right pulmonary artery. Cardiol Young. 2016 Jun; 26(5):999-1001. Su JA, Cheng AL, Szmuszkovicz JR. PMID: 26898218.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    73. Elevated Low-Shear Blood Viscosity is Associated with Decreased Pulmonary Blood Flow in Children with Univentricular Heart Defects. Pediatr Cardiol. 2016 Apr; 37(4):789-801. Cheng AL, Takao CM, Wenby RB, Meiselman HJ, Wood JC, Detterich JA. PMID: 26888364; PMCID: PMC5769474.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    74. Integrative epigenetic profiling analysis identifies DNA methylation changes associated with chronic alcohol consumption. Comput Biol Med. 2015 Sep; 64:299-306. Weng JT, Wu LS, Lee CS, Hsu PW, Cheng AT. PMID: 25555412.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    75. Localization and proteomic characterization of cholesterol-rich membrane microdomains in the inner ear. J Proteomics. 2014 May 30; 103:178-93. Thomas PV, Cheng AL, Colby CC, Liu L, Patel CK, Josephs L, Duncan RK. PMID: 24713161; PMCID: PMC4220796.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    76. Pediatric Cardiology, Cardiac Surgery, and Intensive Care (Ed. Eduardo M. da Cruz, Dunbar Ivy, and James Jaggers). "Biodegradable Implants". 2014. Levi DS, Cheng AL.
    77. A randomized double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: analysis of week 96 results. J Acquir Immune Defic Syndr. 2013 May 01; 63(1):96-100. Zolopa A, Sax PE, DeJesus E, Mills A, Cohen C, Wohl D, Gallant JE, Liu HC, Plummer A, White KL, Cheng AK, Rhee MS, Szwarcberg J, GS-US-236-0102 Study Team. PMID: 23392460.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCellsCTClinical Trials
    78. Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial. Lancet. 2012 Jun 30; 379(9835):2429-2438. DeJesus E, Rockstroh JK, Henry K, Molina JM, Gathe J, Ramanathan S, Wei X, Yale K, Szwarcberg J, White K, Cheng AK, Kearney BP, GS-236-0103 Study Team. PMID: 22748590.
      View in: PubMed   Mentions: 122     Fields:    Translation:HumansCellsCTClinical Trials
    79. The impact of a screensaver in promoting hand hygiene. Am J Infect Control. 2009 Dec; 37(10):867-8. Charters M, Cheng AL, Esaki RK, Kuo AS, Neal J, Thawani JP, Chenoweth C. PMID: 20004813.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    80. Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. N Engl J Med. 2006 Jan 19; 354(3):251-60. Gallant JE, DeJesus E, Arribas JR, Pozniak AL, Gazzard B, Campo RE, Lu B, McColl D, Chuck S, Enejosa J, Toole JJ, Cheng AK, Study 934 Group. PMID: 16421366.
      View in: PubMed   Mentions: 290     Fields:    Translation:HumansCells
    81. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA. 2004 Jul 14; 292(2):191-201. Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD, Coakley DF, Lu B, Toole JJ, Cheng AK, 903 Study Group. PMID: 15249568.
      View in: PubMed   Mentions: 435     Fields:    Translation:HumansCellsCTClinical Trials
    Andrew's Networks
    Concepts (301)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (30)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-40-gb10dcd06 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.